Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.
Gordo-Remartínez S, Calderón-Moreno M, Fernández-Herranz J, Castuera-Gil A, Gallego-Alonso-Colmenares M, Puertas-López C, Nuevo-González JA, Sánchez-Sendín D, García-Gámiz M, Sevillano-Fernández JA, Álvarez-Sala LA, Andueza-Lillo JA, de Miguel-Yanes JM.
Gordo-Remartínez S, et al. Among authors: alvarez sala la.
PLoS One. 2015 Jun 1;10(6):e0125212. doi: 10.1371/journal.pone.0125212. eCollection 2015.
PLoS One. 2015.
PMID: 26030588
Free PMC article.